The Regulatory Division offers our partners quality services locally and regionally by meeting registration deadlines, assisting in developing, compiling registration files, and safeguarding submitted registration prices.

The Medical Division is responsible for communicating product scientific information to the sales force and assist in clinical trial design and implementation, as well as the follow up of our pharmacovigilance system.

Our clinical trial entitled "Effect of Ezetimibe/Atorvastatin Combination on Oxidized LDL-Cholesterol & sPL2 Enzymes in Patients with CAD or CAD Equivalent" was published as Azar R et al. in the American Journal of Cardiology in 2010.

The Scientific Office Division consolidates Pharmaline’s presence on the market and is responsible for promoting our portfolio to the medical community, physicians, and pharmacists.

The Marketing Division builds and secures our brand equity through ethical and strategic initiatives targeting the healthcare community while meeting markets and customer needs.

The Sales Division covers both public sector and private sector. Operating with high-tech handheld devices, our salesforce guarantees accurate market penetration and quality customer service.

The Export Division strengthens our presence in active markets while ensuring access to new potential markets for Pharmaline’s portfolio and partner brands.